Tenofovir Alafenamide Switching Therapy in Kidney or Liver Transplant Recipients With Chronic HBV Infection
Condition:   Safety Issues Intervention:   Drug: Tenofovir Alafenamide 25 MG Sponsor:   Taichung Veterans General Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2022 Category: Research Source Type: clinical trials